PGNY Progyny Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PGNY

Price (delayed)

$56.6

Market cap

$5.01B

P/E Ratio

85.76

Dividend/share

N/A

EPS

$0.66

Enterprise value

$4.99B

Highlights
The EPS has surged by 186% year-on-year and by 22% since the previous quarter
Progyny's gross profit has surged by 58% YoY and by 18% QoQ
PGNY's quick ratio is down by 17% year-on-year and by 7% since the previous quarter
Sector: Healthcare
Industry: Health Information Services

Key stats

What are the main financial stats of PGNY
Market
Shares outstanding
88.53M
Market cap
$5.01B
Enterprise value
$4.99B
Valuations
Price to earnings (P/E)
85.76
Price to book (P/B)
26.74
Price to sales (P/S)
12.82
EV/EBIT
305.14
EV/EBITDA
274.76
EV/Sales
12.93
Earnings
Revenue
$385.97M
EBIT
$16.35M
EBITDA
$18.16M
Free cash flow
$23.88M
Per share
EPS
$0.66
Free cash flow per share
$0.27
Book value per share
$2.12
Revenue per share
$4.42
TBVPS
$3.22
Balance sheet
Total assets
$294.59M
Total liabilities
$109.97M
Debt
$8.1M
Equity
$184.62M
Working capital
$126.8M
Liquidity
Debt to equity
0.04
Current ratio
2.26
Quick ratio
2.21
Net debt/EBITDA
-1.2
Margins
EBITDA margin
4.7%
Gross margin
21.3%
Net margin
14.9%
Operating margin
4.2%
Efficiency
Return on assets
24.8%
Return on equity
38.5%
Return on invested capital
17.3%
Return on capital employed
8.4%
Return on sales
4.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGNY stock price

How has the Progyny stock price performed over time
Intraday
0.87%
1 week
5.52%
1 month
-5.26%
1 year
108.24%
YTD
33.52%
QTD
-4.07%

Financial performance

How have Progyny's revenue and profit performed over time
Revenue
$385.97M
Gross profit
$82.36M
Operating income
$16.3M
Net income
$57.57M
Gross margin
21.3%
Net margin
14.9%
Progyny's operating income has surged by 95% QoQ and by 63% YoY
PGNY's operating margin has surged by 75% since the previous quarter and by 11% year-on-year
Progyny's gross profit has surged by 58% YoY and by 18% QoQ
The revenue is up by 46% year-on-year and by 12% since the previous quarter

Growth

What is Progyny's growth rate over time

Valuation

What is Progyny stock price valuation
P/E
85.76
P/B
26.74
P/S
12.82
EV/EBIT
305.14
EV/EBITDA
274.76
EV/Sales
12.93
The EPS has surged by 186% year-on-year and by 22% since the previous quarter
PGNY's equity has surged by 52% year-on-year and by 11% since the previous quarter
PGNY's price to book (P/B) is 32% higher than its last 4 quarters average of 20.3
The revenue is up by 46% year-on-year and by 12% since the previous quarter
PGNY's price to sales (P/S) is 39% higher than its last 4 quarters average of 9.2

Efficiency

How efficient is Progyny business performance
The company's return on equity has surged by 159% YoY and by 11% QoQ
PGNY's return on invested capital has surged by 116% year-on-year and by 18% since the previous quarter
The return on sales has surged by 68% since the previous quarter
Progyny's return on assets has increased by 9% QoQ

Dividends

What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGNY.

Financial health

How did Progyny financials performed over time
PGNY's total assets is 168% more than its total liabilities
PGNY's total liabilities has surged by 86% year-on-year and by 26% since the previous quarter
PGNY's total assets has soared by 64% YoY and by 16% from the previous quarter
The company's debt is 96% lower than its equity
PGNY's equity has surged by 52% year-on-year and by 11% since the previous quarter
PGNY's debt to equity is down by 20% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.